Wound infections frequently originate from the subcutaneous tissue, Th
e effect of gentamicin in subcutaneous tissue has, however, normally b
een evaluated from concentrations in blood or wound fluid, The aim of
the present study was to investigate the pharmacokinetic properties of
gentamicin in human subcutaneous adipose tissue by a microdialysis te
chnique, Seven healthy young volunteers each had four microdialysis pr
obes placed in the fat (subcutaneous) layer of the abdominal skin, Aft
er the administration of a 240-mg gentamicin intravenous bolus, consec
utive measurements of the drug concentrations in serum and subcutaneou
s interstitial fluid were obtained simultaneously for 6 h, The tissue
gentamicin concentration peaked after 10 to 30 min, The peak concentra
tion in the tissue was 6.7 +/- 2.0 mg . liter(-1) (standard deviation)
, equivalent to 39.1% of the peak concentration in serum, The area und
er the concentration-versus-time curve for the first 6 h in the tissue
was 1,281.7 +/- 390.0) mg . min liter(-1), equivalent to 59.7% of the
area under the concentration-versus-time curve in serum, It is conclu
ded that the microdialysis technique can be used to make dynamic and q
uantitative measurements of the gentamicin concentration in human subc
utaneous tissue, In this adipose tissue, the peak concentrations of ge
ntamicin were approximately seven times the MIC for Pseudomonas aerugi
nosa and 33 times the MIC for Staphylococcus aureus after the administ
ration of an intravenous bolus of 240 mg, indicating the presence of s
ufficient concentrations in the adipose tissue to be effective against
common bacteria.